Australia Stock Exchange release from IDT AUSTRALIA : Australia's 1st mRNA COVID-19 Vaccine Candidate Manufacture
30/11/2021 24:00
Australia Stock Exchange release from IDT AUSTRALIA IDT.AX : Australia's 1st mRNA COVID-19 Vaccine Candidate Manufacture
Recent news on IDT Australia
See all newsBrief: IDT Australia Sees Unaudited Fy26 Revenue From Three Verticals To Rise To A$16.8 Million
IDT Australia soars on upgraded annual earnings forecasts
IDT Australia climbs on positive FY26 outlook
Brief: Idt Australia Forecasts FY26 EBITDA Loss Of A$1.5m-A$2m
IDT Australia eyes strongest session in over four years as EBITDA loss narrows